Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host

Pazopanib Efficacy in Renal Cell Carcinoma: Evidence for Predictive Genetic Markers in Angiogenesis-Related and Exposure-Related Genes

(2011) Chun-Fang Xu et al.   JOURNAL OF CLINICAL ONCOLOGY

International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

(2011)   JOURNAL OF CLINICAL ONCOLOGY

Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

(2011) Xifeng Wu et al.   JNCI-Journal of the National Cancer Institute

Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study

(2011) Jesus Garcia-Donas et al.   LANCET ONCOLOGY

BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer

(2010) A. Font et al.   ANNALS OF ONCOLOGY

Src and Caveolin-1 Reciprocally Regulate Metastasis via a Common Downstream Signaling Pathway in Bladder Cancer

(2010) S. Thomas et al.   CANCER RESEARCH

Cyclin D1/Cyclin-Dependent Kinase 4 Interacts with Filamin A and Affects the Migration and Invasion Potential of Breast Cancer Cells

(2010) Z. Zhong et al.   CANCER RESEARCH

Cyclin D1 G870A Polymorphism Is Associated with Risk and Clinicopathologic Characteristics of Bladder Cancer

(2010) Lin Yuan et al.   DNA AND CELL BIOLOGY

D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance

(2010) Georgia Levidou et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Insulin Breast Cancer Connection: Confirmatory Data Set the Stage for Better Care

(2010) Andrea DeCensi et al.   JOURNAL OF CLINICAL ONCOLOGY

Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants

(2010) Peter H. OʼDonnell et al.   Pharmacogenetics and Genomics

The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary Workshop

(2009) Muin J Khoury et al.   GENETICS IN MEDICINE

Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

(2009) Werner Schroth   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Gastrosplenic Fistula From Hodgkin's Lymphoma

(2009) Carolyn D. Seib et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy: Phase II—Results of EORTC Study 30986

(2009) Maria De Santis et al.   JOURNAL OF CLINICAL ONCOLOGY

Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells

(2009) Chul Jang Kim et al.   MOLECULAR CARCINOGENESIS

From Darwin's Finches to Canaries in the Coal Mine — Mining the Genome for New Biology

(2008) David J. Hunter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic Mapping in Human Disease

(2008) D. Altshuler et al.   SCIENCE